| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $942,751 ) |
| 2025 | 2025 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01NS130484 | Interaction of Motor Learning with Transcranial Direct Current - Efficacy and Mechanisms | 000 | 3 | NIH | 11/27/2024 | $489,315 |
| 2025 | 2025 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM139336 | Discovery and development of artificial nucleic acid ligands to probe cellular interactions | 001 | 6 | NIH | 1/7/2025 | $352,142 |
| 2025 | 2025 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01HL168191 | Hyperglycemia-induced regulatory mechanism of ER stress by arresting domain-containing protein 4 in diabetic cardiomyopathy | 000 | 2 | NIH | 1/2/2025 | $392,500 |
| 2025 | 2025 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01AR081381 | Renewed bone remodeling after pausing long-term bisphosphonate use: Does it replace regions of impaired bone quality and restore mechanical integrity? | 000 | 2 | NIH | 4/1/2025 | $456,674 |
| 2025 | 2025 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01CA247910 | Machine learning for risk-adjusted breast MRI screening | 000 | 5 | NIH | 11/19/2024 | $596,618 |
| 2025 | 2025 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16NS129675 | Role of uptake2 in neuroprotective signaling | 000 | 3 | NIH | 1/24/2025 | $23,027 |
| 2025 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM139336 | Discovery and development of artificial nucleic acid ligands to probe cellular interactions | 000 | 5 | NIH | 11/4/2024 | $0 |
| 2025 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01NS112996 | kHz frequency Spinal Cord Stimulation: Novel Temperature-Based Mechanisms of Action | 001 | 2 | NIH | 1/21/2025 | $9,456 |
| 2025 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01AI139103 | The Role of Type VI Secretion in Cholera Pathogenesis | 000 | 5 | NIH | 1/3/2025 | $0 |
| 2025 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R34MH121295 | Optimizing Study Design to Test a Community-level Intervention to Reduce Intersectional Stigma and Increase HIV Testing and Prevention among African-American/Black MSM | 001 | 3 | NIH | 10/9/2024 | -$1 |
| 2025 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01MH129198 | Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention among African-American/Black Gay, Bisexual and Same-gender Loving Men | 001 | 2 | NIH | 1/6/2025 | -$668,847 |
| 2025 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01MH129198 | Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention among African-American/Black Gay, Bisexual and Same-gender Loving Men | 000 | 1 | NIH | 1/6/2025 | -$112,564 |
| 2025 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R21HD106607 | Novel bone specific pharmacological treatment for osteogenesis imperfecta | 001 | 2 | NIH | 1/13/2025 | -$7 |
| 2025 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T34GM007639 | MARC Honors Undergraduate Research Training Program | 000 | 40 | NIH | 12/9/2024 | -$109,165 |
| 2025 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R21HD106607 | Novel bone specific pharmacological treatment for osteogenesis imperfecta | 000 | 2 | NIH | 12/15/2024 | $0 |
| 2025 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R21DC019737 | Development of hemispheric specializations during Auditory Cortex critical periods | 000 | 2 | NIH | 10/8/2024 | -$3,638 |
| 2025 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R21DC019737 | Development of hemispheric specializations during Auditory Cortex critical periods | 001 | 2 | NIH | 10/8/2024 | -$2,611 |
| 2025 | 2021 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R25NS076414 | Mentoring Institute for Neuroscience Diversity Scholars | 002 | 9 | NIH | 1/23/2025 | -$268,218 |
| 2025 | 2021 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R34MH121295 | Optimizing Study Design to Test a Community-level Intervention to Reduce Intersectional Stigma and Increase HIV Testing and Prevention among African-American/Black MSM | 000 | 3 | NIH | 10/9/2024 | $0 |
| 2025 | 2021 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01NS112996 | kHz frequency Spinal Cord Stimulation: Novel Temperature-Based Mechanisms of Action | 000 | 1 | NIH | 1/21/2025 | -$9,456 |
| 2025 | 2020 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R25NS076414 | Mentoring Institute for Neuroscience Diversity Scholars | 001 | 8 | NIH | 1/23/2025 | -$190,476 |
| 2025 | 2020 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R21NS116028 | Molecular Mechanisms of Excitotoxic Neurodegeneration: Novel Death Pathways in C. Elegans | 000 | 1 | NIH | 3/18/2025 | -$11,998 |
|
 | Issue Date FY: 2024 ( Subtotal = $11,507,291 ) (Continued on the next page) |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T34GM137870 | Bridges to the Baccalaureate Research Training Program (T34) for racial/ethnic minorities at the Borough of Manhattan Community College (BMCC) and the City College of New York (CCNY) | 000 | 4 | NIH | 8/16/2024 | $350,862 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | U54MD017979 | NYCenter for Minority Health, Equity and Social Justice | 000 | 1 | NIH | 8/23/2024 | $3,939,001 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01CA247910 | Machine learning for risk-adjusted breast MRI screening | 001 | 4 | NIH | 4/17/2024 | $33,147 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01CA247910 | Machine learning for risk-adjusted breast MRI screening | 000 | 4 | NIH | 11/10/2023 | $596,618 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM139336 | Discovery and development of artificial nucleic acid ligands to probe cellular interactions | 004 | 5 | NIH | 5/20/2024 | $39,126 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM139336 | Discovery and development of artificial nucleic acid ligands to probe cellular interactions | 000 | 5 | NIH | 11/27/2023 | $352,142 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 004 | 3 | NIH | 8/28/2024 | $99,999 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 005 | 3 | NIH | 8/29/2024 | $25,374 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 003 | 3 | NIH | 8/1/2024 | $92,881 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 002 | 2 | NIH | 7/31/2024 | $2,308 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 001 | 3 | NIH | 7/23/2024 | $157,000 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 000 | 2 | NIH | 6/18/2024 | $15,480 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01HL168191 | Hyperglycemia-induced regulatory mechanism of ER stress by arresting domain-containing protein 4 in diabetic cardiomyopathy | 000 | 1 | NIH | 1/9/2024 | $392,500 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01HL166620 | Arrestin domain-containing protein 4 as a novel regulator of glucose metabolism in the ischemic heart | 000 | 2 | NIH | 7/5/2024 | $384,650 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145474 | Microcalcifications in Atherosclerotic Plaque | 000 | 3 | NIH | 8/13/2024 | $157,000 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16NS129675 | Role of uptake2 in neuroprotective signaling | 000 | 3 | NIH | 4/25/2024 | $157,000 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145496 | Explaining the variability in focused ultrasound neuromodulation | 000 | 3 | NIH | 6/5/2024 | $158,150 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM142833 | Integrating Real-Time Multi-System Cytokine Signaling in Chronic Disease | 001 | 4 | NIH | 5/21/2024 | $21,062 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM142833 | Integrating Real-Time Multi-System Cytokine Signaling in Chronic Disease | 000 | 4 | NIH | 5/20/2024 | $392,500 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | SC1GM139701 | Mechanism of membrane fusion involving the Gram-negative bacteria outer membrane | 001 | 4 | NIH | 7/19/2024 | $37,825 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | SC1GM139701 | Mechanism of membrane fusion involving the Gram-negative bacteria outer membrane | 000 | 4 | NIH | 4/8/2024 | $340,425 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T32GM136499 | G-RISE at The City College of New York | 002 | 5 | NIH | 9/13/2024 | $102,694 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T32GM136499 | G-RISE at The City College of New York | 001 | 5 | NIH | 7/1/2024 | $24,996 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T32GM136499 | G-RISE at The City College of New York | 000 | 5 | NIH | 4/12/2024 | $600,075 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01NS112996 | kHz frequency Spinal Cord Stimulation: Novel Temperature-Based Mechanisms of Action | 001 | 3 | NIH | 4/26/2024 | $317,925 |
| 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R03AR084261 | Osteogenesis imperfecta caused by TMEM38B mutation: a deep investigation of cellular and extracellular consequences to identify new therapeutic targets | 001 | 1 | NIH | 9/26/2024 | $0 |
|